BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26424270)

  • 1. Thioredoxin-Displayed Multipeptide Immunogens.
    Bolchi A; Canali E; Santoni A; Spagnoli G; Viarisio D; Accardi R; Tommasino M; Müller M; Ottonello S
    Methods Mol Biol; 2015; 1348():137-51. PubMed ID: 26424270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high-performance thioredoxin-based scaffold for peptide immunogen construction: proof-of-concept testing with a human papillomavirus epitope.
    Canali E; Bolchi A; Spagnoli G; Seitz H; Rubio I; Pertinhez TA; Müller M; Ottonello S
    Sci Rep; 2014 Apr; 4():4729. PubMed ID: 24751665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory production of designed multipeptides displayed on a thermostable bacterial thioredoxin scaffold in Pichia pastoris.
    Spagnoli G; Bolchi A; Cavazzini D; Pouyanfard S; Müller M; Ottonello S
    Protein Expr Purif; 2017 Jan; 129():150-157. PubMed ID: 27133916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent anti-HPV immune responses induced by tandem repeats of the HPV16 L2 (20 -- 38) peptide displayed on bacterial thioredoxin.
    Rubio I; Bolchi A; Moretto N; Canali E; Gissmann L; Tommasino M; Müller M; Ottonello S
    Vaccine; 2009 Mar; 27(13):1949-56. PubMed ID: 19368776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines.
    Cavazzini D; Spagnoli G; Mariz FC; Reggiani F; Maggi S; Franceschi V; Donofrio G; Müller M; Bolchi A; Ottonello S
    Front Immunol; 2022; 13():958123. PubMed ID: 36032169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor Capsid Protein L2 Polytope Induces Broad Protection against Oncogenic and Mucosal Human Papillomaviruses.
    Pouyanfard S; Spagnoli G; Bulli L; Balz K; Yang F; Odenwald C; Seitz H; Mariz FC; Bolchi A; Ottonello S; Müller M
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
    Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
    J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions.
    Lu Z; Murray KS; Van Cleave V; LaVallie ER; Stahl ML; McCoy JM
    Biotechnology (N Y); 1995 Apr; 13(4):366-72. PubMed ID: 9634778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Shot Generation of Epitope-Directed Monoclonal Antibodies to Multiple Nonoverlapping Targets: Peptide Selection, Antigen Preparation, and Epitope Mapping.
    Liew OW; Ling SSM; Lilyanna S; Chong JPC; Ng JYX; Richards AM
    Methods Mol Biol; 2023; 2578():121-141. PubMed ID: 36152284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the 'switch-epitope' concept with random peptide libraries displayed as thioredoxin loop fusions.
    Tripp BC; Lu Z; Bourque K; Sookdeo H; McCoy JM
    Protein Eng; 2001 May; 14(5):367-77. PubMed ID: 11438760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of phage pIII, pVIII and GST as carrier proteins for peptide immunisation in Balb/c mice.
    Yip YL; Smith G; Ward RL
    Immunol Lett; 2001 Dec; 79(3):197-202. PubMed ID: 11600198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combinatorial mutagenesis approach for functional epitope mapping on phage-displayed target antigen: application to antibodies against epidermal growth factor.
    Infante YC; Pupo A; Rojas G
    MAbs; 2014; 6(3):637-48. PubMed ID: 24589624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.
    He L; Cheng Y; Kong L; Azadnia P; Giang E; Kim J; Wood MR; Wilson IA; Law M; Zhu J
    Sci Rep; 2015 Aug; 5():12501. PubMed ID: 26238798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative characteristic of the methods of protein antigens epitope mapping].
    Halkin OIu
    Ukr Biochem J; 2014; 86(4):164-77. PubMed ID: 25509196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asparaginase display of polypeptides in the periplasm of Escherichia coli: potential rapid pepscan technique for antigen epitope mapping.
    Gaofu Q; Jie L; Rongyue C; Xin Y; Dan M; Jie W; Xiangchun S; Qunwei X; Roque RS; Xiuyun Z; Jingjing L
    J Immunol Methods; 2005 Apr; 299(1-2):9-19. PubMed ID: 15914188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The localization of two mimic epitopes of lipopolysaccharide binding protein and the preparation of their tandem multiple antigen peptide.
    Feng YK; Yang QH; Liu YS; Xu JC; Qian GS; Wang YH
    J Immunol Methods; 2010 Oct; 362(1-2):60-9. PubMed ID: 20833181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
    Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
    Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
    Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
    J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broad Neutralization Responses Against Oncogenic Human Papillomaviruses Induced by a Minor Capsid L2 Polytope Genetically Incorporated Into Bacterial Ferritin Nanoparticles.
    Yang F; Mariz FC; Zhao X; Spagnoli G; Ottonello S; Müller M
    Front Immunol; 2020; 11():606569. PubMed ID: 33343580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.